MARKER THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
MARKER THERAPEUTICS, INC. (MRKR) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$275.47 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- MARKER THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$889.77K, a 600.42% decline year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $614.30K, a 82.77% increase year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$365.26K.
- MARKER THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$603.22K, a 168.73% decline year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$454.57K, a 5288.56% decline from fiscal 2024.
- MARKER THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $8.76K.
- MARKER THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$718.39K.
- MARKER THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$1.32M, a 131.87% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 143 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 146 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 149 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 152 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 155 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 158 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 161 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 164 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 164 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 167 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 170 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 173 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 173 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 179 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$889.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$275.47K 10-Q · filed 2026-08-14 | -$640.73K derived: sum of 3 quarters · filed 2026-08-14 | -$1.24M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||||
| 2026-03-31 | $614.30K 10-Q · filed 2026-05-15 | $249.04K derived: sum of 2 quarters · filed 2026-05-15 | -$354.19K derived: sum of 3 quarters · filed 2026-05-15 | -$176.38K derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||||
| 2025-12-31 | -$365.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$968.49K derived: sum of 2 quarters · filed 2026-03-18 | -$790.68K derived: sum of 3 quarters · filed 2026-08-14 | -$454.57K 10-K · filed 2026-03-18 | ||||||||||||||||||
| 2025-09-30 | -$603.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$425.42K derived: sum of 2 quarters · filed 2026-08-14 | -$89.31K 10-Q · filed 2025-11-13 | -$892.69K derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||||
| 2025-06-30 | $177.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $513.92K 10-Q · filed 2026-08-14 | -$289.46K derived: sum of 3 quarters · filed 2026-08-14 | $588.20K derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||||
| 2025-03-31 | $336.11K 10-Q · filed 2026-05-15 | -$467.27K derived: sum of 2 quarters · filed 2026-05-15 | $410.40K derived: sum of 3 quarters · filed 2026-05-15 | $140.37K derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||||||||
| 2024-12-31 | -$803.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $74.28K derived: sum of 2 quarters · filed 2026-03-18 | -$195.75K derived: sum of 3 quarters · filed 2026-03-18 | $8.76K 10-K · filed 2026-03-18 | ||||||||||||||||||
| 2024-09-30 | $877.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $607.63K derived: sum of 2 quarters · filed 2025-11-13 | $812.14K 10-Q · filed 2025-11-13 | $253.32K derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||||||||||
| 2024-06-30 | -$270.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$65.52K 10-Q · filed 2025-08-14 | -$624.35K derived: sum of 3 quarters · filed 2025-08-14 | -$980.94K derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||||||
| 2024-03-31 | $204.51K 10-Q · filed 2025-05-15 | -$354.32K derived: sum of 2 quarters · filed 2025-05-15 | -$710.92K derived: sum of 3 quarters · filed 2025-05-15 | -$625.06K derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||||||||
| 2023-12-31 | -$558.83K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$915.42K derived: sum of 2 quarters · filed 2025-03-31 | -$829.56K derived: sum of 3 quarters · filed 2025-03-31 | -$718.39K 10-K · filed 2025-03-31 | $611.26K 10-K · filed 2024-03-26 | |||||||||||||||||
| 2023-09-30 | -$356.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$270.74K derived: sum of 2 quarters · filed 2024-11-14 | -$159.57K 10-Q · filed 2024-11-14 | $208.35K 10-Q · filed 2023-11-09 | -$1.19M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||||||||
| 2023-06-30 | $85.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $197.03K 10-Q · filed 2024-08-14 | -$833.53K derived: sum of 3 quarters · filed 2024-08-14 | -$61.12K derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||||||||||
| 2023-03-31 | $111.17K 10-Q · filed 2024-05-15 | -$250.02K 10-Q · filed 2023-05-15 | -$919.39K derived: sum of 2 quarters · filed 2024-05-15 | -$146.98K derived: sum of 3 quarters · filed 2024-05-15 | $2.75M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||||||||
| 2022-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$258.15K derived: sum of 2 quarters · filed 2024-03-26 | $2.63M derived: sum of 3 quarters · filed 2024-03-26 | -$1.32M 10-K · filed 2024-03-26 | -$4.30M 10-K · filed 2023-03-22 | |||||||||||||||||
| 2022-09-30 | $772.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.66M derived: sum of 2 quarters · filed 2023-11-09 | -$289.15K 10-Q · filed 2023-11-09 | -$3.31M 10-Q · filed 2022-11-10 | $1.11M derived: sum of 4 quarters · filed 2023-11-09 | |||||||||||||||||
| 2022-06-30 | $2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.06M 10-Q · filed 2023-08-14 | -$4.26M 10-Q · filed 2022-08-11 | $337.70K derived: sum of 3 quarters · filed 2023-08-14 | $2.97M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||||||||
| 2022-03-31 | -$3.95M 10-Q · filed 2023-05-15 | -$2.55M derived: sum of 2 quarters · filed 2023-05-15 | $79.21K derived: sum of 3 quarters · filed 2023-05-15 | $1.67M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||||||||
| 2021-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $4.03M derived: sum of 2 quarters · filed 2023-03-22 | $5.62M derived: sum of 3 quarters · filed 2023-03-22 | $4.14M 10-K · filed 2023-03-22 | ||||||||||||||||||
| 2021-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $4.22M derived: sum of 2 quarters · filed 2022-11-10 | $2.74M 10-Q · filed 2022-11-10 | $3.72M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||||||||
| 2021-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $108.23K 10-Q · filed 2022-08-11 | -$912.07K 10-Q · filed 2021-08-10 | $1.09M derived: sum of 3 quarters · filed 2022-08-11 | $385.30K derived: sum of 4 quarters · filed 2022-08-11 | |||||||||||||||||
| 2021-03-31 | -$1.48M 10-Q · filed 2022-05-13 | -$2.44M 10-Q · filed 2021-05-12 | -$500.99K derived: sum of 2 quarters · filed 2022-05-13 | -$1.21M derived: sum of 3 quarters · filed 2022-05-13 | $367.32K derived: sum of 4 quarters · filed 2022-05-13 | |||||||||||||||||
| 2020-12-31 | $981.48K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $277.07K derived: sum of 2 quarters · filed 2022-03-17 | $1.85M derived: sum of 3 quarters · filed 2022-03-17 | $3.05M 10-K · filed 2022-03-17 | $4.22M 10-K · filed 2021-03-09 | |||||||||||||||||
| 2020-09-30 | -$704.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $868.32K derived: sum of 2 quarters · filed 2021-11-10 | $2.07M 10-Q · filed 2021-11-10 | $3.96M 10-Q · filed 2020-11-09 | $964.80K derived: sum of 4 quarters · filed 2021-11-10 | |||||||||||||||||
| 2020-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $2.77M 10-Q · filed 2021-08-10 | $1.67M derived: sum of 3 quarters · filed 2021-08-10 | $1.58M derived: sum of 4 quarters · filed 2021-08-10 | ||||||||||||||||||
| 2020-03-31 | $1.20M 10-Q · filed 2021-05-12 | $96.48K derived: sum of 2 quarters · filed 2021-05-12 | $8.51K derived: sum of 3 quarters · filed 2021-05-12 | $261.27K derived: sum of 4 quarters · filed 2021-05-12 | ||||||||||||||||||
| 2019-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$1.19M derived: sum of 2 quarters · filed 2021-03-09 | -$936.34K derived: sum of 3 quarters · filed 2021-03-09 | -$963.97K 10-K · filed 2021-03-09 | ||||||||||||||||||
| 2019-09-30 | -$87.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $164.79K derived: sum of 2 quarters · filed 2020-11-09 | $137.16K 10-Q · filed 2020-11-09 | -$702.04K derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||||||||
| 2019-06-30 | $252.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $225.13K 10-Q · filed 2020-08-10 | -$614.06K derived: sum of 3 quarters · filed 2020-08-10 | -$620.45K derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||||||||
| 2019-03-31 | -$27.63K 10-Q · filed 2020-05-11 | -$866.83K derived: sum of 2 quarters · filed 2020-05-11 | -$873.21K derived: sum of 3 quarters · filed 2020-05-11 | $420.78K derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||||||||
| 2018-12-31 | -$839.20K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$845.58K derived: sum of 2 quarters · filed 2020-03-12 | $448.41K derived: sum of 3 quarters · filed 2020-03-12 | $1.24M 10-K · filed 2020-03-12 | ||||||||||||||||||
| 2018-09-30 | -$6.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.29M derived: sum of 2 quarters · filed 2019-11-12 | $2.08M 10-Q · filed 2019-11-12 | $1.83M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||||||
| 2018-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $2.09M 10-Q · filed 2019-08-09 | $1.84M derived: sum of 3 quarters · filed 2019-08-09 | $2.03M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||||||||||
| 2018-03-31 | $792.85K 10-Q · filed 2019-05-10 | $544.10K derived: sum of 2 quarters · filed 2019-05-10 | $740.09K derived: sum of 3 quarters · filed 2019-05-10 | $851.97K derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||||||||||
| 2017-12-31 | -$248.75K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$52.76K derived: sum of 2 quarters · filed 2019-03-15 | $59.12K derived: sum of 3 quarters · filed 2019-03-15 | $283.37K 10-K · filed 2019-03-15 | ||||||||||||||||||
| 2017-09-30 | $195.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $307.87K derived: sum of 2 quarters · filed 2018-11-13 | $532.12K 10-Q · filed 2018-11-13 | $78.98K derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||||||||||
| 2017-06-30 | $111.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $336.13K 10-Q · filed 2018-08-09 | -$117.00K derived: sum of 3 quarters · filed 2018-08-09 | $23.68K derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||||
| 2017-03-31 | $224.25K 10-Q · filed 2018-05-15 | -$228.89K derived: sum of 2 quarters · filed 2018-05-15 | -$88.20K derived: sum of 3 quarters · filed 2018-05-15 | -$196.72K derived: sum of 4 quarters · filed 2018-05-15 | ||||||||||||||||||
| 2016-12-31 | -$453.14K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | -$312.45K derived: sum of 2 quarters · filed 2018-03-23 | -$420.97K derived: sum of 3 quarters · filed 2018-03-23 | $257.58K 10-K · filed 2018-03-23 | ||||||||||||||||||
| 2016-09-30 | $140.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $32.16K derived: sum of 2 quarters · filed 2017-11-14 | $710.72K 10-Q · filed 2017-11-14 | $601.78K derived: sum of 4 quarters · filed 2017-11-14 | ||||||||||||||||||
| 2016-06-30 | -$108.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $570.03K 10-Q · filed 2017-08-07 | $461.10K derived: sum of 3 quarters · filed 2017-08-07 | $516.73K derived: sum of 4 quarters · filed 2017-08-07 | ||||||||||||||||||
| 2016-03-31 | $678.55K 10-Q · filed 2017-05-05 | $569.62K derived: sum of 2 quarters · filed 2017-05-05 | $625.25K derived: sum of 3 quarters · filed 2017-05-05 | $764.61K derived: sum of 4 quarters · filed 2017-05-05 | ||||||||||||||||||
| 2015-12-31 | -$108.94K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$53.30K derived: sum of 2 quarters · filed 2017-03-14 | $86.06K derived: sum of 3 quarters · filed 2017-03-14 | $96.02K 10-K · filed 2017-03-14 | ||||||||||||||||||
| 2015-09-30 | $55.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $195.00K derived: sum of 2 quarters · filed 2016-11-04 | $204.96K 10-Q · filed 2016-11-04 | -$231.60K derived: sum of 4 quarters · filed 2016-11-04 | ||||||||||||||||||
| 2015-06-30 | $139.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $149.32K 10-Q · filed 2016-08-15 | -$287.24K derived: sum of 3 quarters · filed 2016-08-15 | -$318.16K derived: sum of 4 quarters · filed 2016-08-15 | ||||||||||||||||||
| 2015-03-31 | $9.96K 10-Q · filed 2016-05-16 | -$426.60K derived: sum of 2 quarters · filed 2016-05-16 | -$457.51K derived: sum of 3 quarters · filed 2016-05-16 | -$294.15K derived: sum of 4 quarters · filed 2016-05-16 | ||||||||||||||||||
| 2014-12-31 | -$436.56K derived: 10-K 12 month − 10-Q/A 9 month · filed 2016-04-14 | -$467.48K derived: sum of 2 quarters · filed 2016-04-14 | -$304.11K derived: sum of 3 quarters · filed 2016-04-14 | -$145.20K 10-K · filed 2016-04-14 | ||||||||||||||||||
| 2014-09-30 | -$30.92K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2016-04-14 | $132.45K derived: sum of 2 quarters · filed 2016-04-14 | $291.36K 10-Q/A · filed 2016-04-14 | $1.41M derived: sum of 4 quarters · filed 2016-04-14 | ||||||||||||||||||
| 2014-06-30 | $163.36K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-04-14 | $322.28K 10-Q/A · filed 2016-04-14 | $1.44M derived: sum of 3 quarters · filed 2016-04-14 | $1.09M derived: sum of 4 quarters · filed 2016-04-14 | $8.40M 10-Q · filed 2014-08-18 | |||||||||||||||||
| 2014-03-31 | $158.91K 10-Q/A · filed 2016-04-14 | $158.41K 10-Q/A · filed 2014-05-21 | $1.28M derived: sum of 2 quarters · filed 2016-04-14 | $930.49K derived: sum of 3 quarters · filed 2016-04-14 | $1.36M derived: sum of 4 quarters · filed 2016-04-14 | |||||||||||||||||
| 2013-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $771.58K derived: sum of 2 quarters · filed 2015-04-15 | $1.20M derived: sum of 3 quarters · filed 2015-04-15 | $2.48M 10-K/A · filed 2014-04-17 | $8.24M 10-Q/A · filed 2014-05-21 | $8.06M 10-K/A · filed 2014-04-17 | ||||||||||||||||
| 2013-09-30 | -$347.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $85.81K derived: sum of 2 quarters · filed 2014-11-19 | $716.37K 10-Q · filed 2014-11-19 | $1.81M derived: sum of 4 quarters · filed 2014-11-19 | $6.31M 10-Q · filed 2013-11-19 | |||||||||||||||||
| 2013-06-30 | $433.18K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-18 | $1.06M 10-Q · filed 2014-08-18 | $2.16M derived: sum of 3 quarters · filed 2014-08-18 | $2.51M derived: sum of 4 quarters · filed 2014-08-18 | $6.66M 10-Q · filed 2013-08-19 | |||||||||||||||||
| 2013-03-31 | $630.56K 10-Q/A · filed 2014-05-21 | $539.35K 10-Q · filed 2013-05-21 | $1.72M derived: sum of 2 quarters · filed 2014-05-21 | $2.07M derived: sum of 3 quarters · filed 2014-05-21 | $2.64M derived: sum of 4 quarters · filed 2014-05-21 | $6.23M 10-Q/A · filed 2013-08-19 | $6.15M 10-Q · filed 2013-05-21 | |||||||||||||||
| 2012-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | $1.44M derived: sum of 2 quarters · filed 2013-11-19 | $2.01M derived: sum of 3 quarters · filed 2013-11-19 | $2.02M 10-K/A · filed 2014-04-17 | $5.61M 10-K · filed 2013-05-15 | |||||||||||||||||
| 2012-09-30 | $350.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $916.39K derived: sum of 2 quarters · filed 2013-11-19 | $940.66K 10-Q · filed 2013-11-19 | $919.88K 10-Q · filed 2012-11-19 | $789.52K derived: sum of 4 quarters · filed 2013-11-19 | $4.50M 10-Q · filed 2012-11-19 | ||||||||||||||||
| 2012-06-30 | $565.54K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-19 | $589.81K 10-Q · filed 2013-08-19 | $469.81K 10-Q/A · filed 2012-09-12 | $438.67K derived: sum of 3 quarters · filed 2013-08-19 | $728.33K derived: sum of 4 quarters · filed 2013-08-19 | $4.05M 10-Q/A · filed 2012-09-12 | ||||||||||||||||
| 2012-03-31 | $24.27K 10-Q/A · filed 2013-08-19 | -$126.88K derived: sum of 2 quarters · filed 2013-08-19 | $162.78K derived: sum of 3 quarters · filed 2013-08-19 | $194.91K derived: sum of 4 quarters · filed 2013-08-19 | $3.61M 10-Q · filed 2012-05-21 | |||||||||||||||||
| 2011-12-31 | -$151.14K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | $138.51K derived: sum of 2 quarters · filed 2013-05-15 | $170.64K derived: sum of 3 quarters · filed 2013-05-15 | -$66.12K 10-K · filed 2013-05-15 | $3.58M 10-K · filed 2012-04-16 | |||||||||||||||||
| 2011-09-30 | $289.66K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $321.79K derived: sum of 2 quarters · filed 2012-11-19 | $85.02K 10-Q · filed 2012-11-19 | $845.47K derived: sum of 4 quarters · filed 2012-11-19 | $3.30M 10-Q · filed 2011-11-21 | |||||||||||||||||
| 2011-06-30 | $32.13K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-12 | -$204.64K 10-Q/A · filed 2012-09-12 | $555.82K derived: sum of 3 quarters · filed 2012-09-12 | $695.82K derived: sum of 4 quarters · filed 2012-09-12 | $3.01M 10-Q · filed 2011-08-22 | |||||||||||||||||
| 2011-03-31 | -$236.77K 10-Q · filed 2012-05-21 | $523.69K derived: sum of 2 quarters · filed 2012-05-21 | $663.69K derived: sum of 3 quarters · filed 2012-05-21 | |||||||||||||||||||
| 2010-12-31 | $760.46K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $900.46K derived: sum of 2 quarters · filed 2012-04-16 | $1.16M 10-K · filed 2012-04-16 | |||||||||||||||||||
| 2010-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $401.13K 10-Q · filed 2011-11-21 | ||||||||||||||||||||
| 2010-06-30 | $261.13K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |